Target intelligence / Profile preview

Msh homeobox 2 pseudogene 1 (MSX2P1)

Target
MSX2P1
Molecular classification
Pseudogene, Homeobox pseudogene, Non-coding RNA locus
01

Overview

Msh homeobox 2 pseudogene 1 (MSX2P1) is a human pseudogene located at chromosome 17q23.2. It arose via retrotransposition of MSX2 mRNA and shares high sequence identity with MSX2 but lacks introns and protein-coding capacity. The locus contains remnants of a poly(A) tail, and like other pseudogenes, it is not thought to encode functional proteins. In some contexts, non-coding RNAs from MSX2P1 have been implicated in aberrant cellular proliferation, but there is no evidence for its direct involvement in human disease as a classical gene or pharmacological target. Key distinction: MSX2P1 is sometimes confused with MSX2, a homeobox transcription factor important in craniofacial development and several disease states. Only MSX2—not MSX2P1—is a conventional molecular target with protein-coding function. Summary: MSX2P1 should not be considered a drug target, receptor, or functional entity in the conventional sense. Its aliases and history reflect database entries for non-coding or retroposed loci, not for a canonical protein or molecular target.

Other names
HSHPX5HPX5MSX2Pmsh homeobox 2 pseudogene 1
02

Mechanism of action

None

03

Biological functions

None known for MSX2P1 as a pseudogene. If expressed, certain lncRNAs derived from this locus may have regulatory roles in specific contexts.
04

Disease associations

None known directly for MSX2P1Some studies suggest lncRNAs from MSX2P1 may be relevant to abnormal keratinocyte proliferation in psoriasis, but not as a conventional protein target.
05

Biomarkers

None established for patient selection or efficacy monitoringExploratory roles for lnc-MSX2P1 transcripts in keratinocyte-related conditions have been studied in research settings.

Beyond the preview

Go deeper on Msh homeobox 2 pseudogene 1 (MSX2P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Msh homeobox 2 pseudogene 1 (MSX2P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call